Anticancer Prodrugs: An Overview of Major Strategies and Recent Developments

E-ISSN： 1873-4294|11|18|2346-2381

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.18, 2011-09, pp. : 2346-2381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imidazoquinolines: Recent Developments in Anticancer Activity

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-03 ,pp. : 309-322

Bentham Science Publishers

Access to resources Recommend Favorite

Prodrugs for Targeted Tumor Therapies: Recent Developments in ADEPT, GDEPT and PMT

Current Pharmaceutical Design, Vol. 17, Iss. 32, 2011-11 ,pp. : 3527-3547

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in anticancer nitric oxide donors

By Cai T Bill Wang Peng George

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 849-857

Informa Healthcare

Access to resources Recommend Favorite

Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy

Current Pharmaceutical Design, Vol. 23, Iss. 16, 2017-06 ,pp. : 2366-2376

Bentham Science Publishers

Access to resources Recommend Favorite

Overview and recent developments in the medical management of paediatric uveitis

By Pilly Bertrand

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 13, 2013-09 ,pp. : 1787-1795

Informa Healthcare

Access to resources Recommend Favorite